Abstract Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to
reduced endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the …

Background Circulating endothelial progenitor cells (EPCs) reflect endothelial repair
capacity and may be a significant marker for the clinical outcomes of cardiovascular disease …

Numerous clinical trials have demonstrated early reductions in cardiovascular events
occurring independently of the lipid-lowering effects of statins. These pleiotropic effects have …

The effect of statins on endothelial progenitor cells (EPCs) function derived from diabetic
patients (DMpts) with acute myocardial infarction (AMI) is unknown. In this study we assess …

Statins appear to be potent drugs with a variety of pleiotropic effects with vasculoprotective
and cardioprotective activity. The beneficial effects of statins on endothelial cells as well as …

In recent years, endothelial progenitor cells (EPCs) have been demonstrated to play an
important role during tissue vascularization and endothelium homeostasis in adults. In …

Statins are potent drugs with a variety of cardiovascular protective effects which appear to
occur independent of cholesterol reduction. The vasculoprotective effects of statins might be …

Background—Therapeutic neovascularization may constitute an important strategy to
salvage tissue from critical ischemia. Circulating bone marrow–derived endothelial …

Statins reduce atherosclerotic events and cardiovascular mortality. Their side effects include
memory loss, myopathy, cataract formation, and increased risk of diabetes. As …

Endothelial dysfunction, a well recognized marker of cardiovascular risk, is an early event in
artheriosclerosis process. Diabetes mellitus, hypertension and dyslipidemia, known risk …